Forbes Media Hosts Sixth Annual Healthcare Summit – Forbes

“Forbes Healthcare Summit 2017: Healing Medicine’s Pain Points”

Speakers include Martine Rothblatt from United Therapeutics, Vas Narasimhan from Novartis, Kenneth Frazier from Merck & Co. and Stefano Pessina from Walgreens Boots Alliance

November 29 – 30, 2017 New York, NY


NEW YORK (October 26, 2017) –The sixth annual “Forbes Healthcare Summit 2017: Healing Medicine’s Pain Points” will convene the top leaders in the healthcare industry at Jazz at Lincoln Center in New York City on November 29 –30, 2017. At the invitation-only summit, participants will gather to discuss breakthrough ideas to solve challenges battering the healthcare industry. World-class CEOs and industry experts will come together to unveil the latest breakthroughs in science, tackle controversial issues and turn the healthcare system’s challenges into new opportunities.

Forbes has developed an agenda that focuses on the opportunities and challenges that are currently top of mind for leaders and influencers in the healthcare industry.  Topics of discussion will include the opioid epidemic, how artificial intelligence is changing healthcare, gene therapy, pharmaceutical controversies, technology that’s transforming public health and more.

“Nothing is more important than health. But improvements in our healthcare system are often stymied by the siloed perspectives of different parts of the industry,” said Matthew Herper, Senior Editor, Forbes Media.  “As we have for six years, we’re gathering the top leaders from across the health business to discuss what steps can be taken to make sure that all health companies are delivering for their most important constituency: patients.”

Speakers at the summit include:

  • Pharma Innovators: Carsten Brunn, Head of Pharmaceuticals, Americas Region, Bayer; Kenneth Frazier, Chairman and CEO of Merck & Co.; John Maraganore, Chief Executive Officer, Alnylam; Vas Narasimhan, M.D., Global Head of Drug Development & Chief Medical Officer, Novartis; Ian Read, Chairman and CEO of Pfizer; David A. Ricks, Chairman & Chief Executive Officer, Eli Lilly & Company; Brent Saunders, CEO & President, Allergan plc; Leonard Schleifer, MD, Ph.D., President & Chief Executive Officer, Regeneron; Stephen Ubl, President & Chief Executive Officer, Pharmaceutical Research and Manufacturers of America
  • Caregivers: Thomas R. Frieden, M.D., M P H, Former Director, Centers for Disease Control & Prevention; President & Chief Executive Officer, Resolve to Save Lives; Laurie H. Glimcher, M.D., President & Chief Executive Officer, Dana-Farber Cancer Institute; Patrice A. Harris, M.D., M.A., Immediate Past Chair, Board of Trustees, American Medical Association; Andrew Kolodny, MD, Co-Director of The Opioid Policy Research Collaborative, The Heller School for Social Policy & Management; Barry H. Ostrowsky, President & Chief Executive Officer, RWJBarnabas Health; Stefano Pessina, Executive Vice Chairman & CEO, Walgreens Boots Alliance; Steven M. Safyer, M.D., President & Chief Executive Officer, Montefiore Medicine, Michael Dowling, President & Chief Executive Officer, Northwell Health
  • Value Creators: Jonathan Bush, Co-Founder & Chief Executive Officer, athenahealth; August Calhoun, PhD, Senior Vice President, Healthcare Services, Siemens Healthineers; Diane P. Holder, President & Chief Executive Officer, UPMC Health Plan; Thomas M. Moriarty, Executive Vice President, Chief Policy & External Affairs Officer, and General Counsel, CVS Health; Steve Nelson, Chief Executive Officer, UnitedHealthcare; Tim Wentworth, President & Chief Executive Officer, Express-Scripts
  • Pioneers: Arie Belldegrun, M.D., FACS, Founder, Chairman & Chief Executive Officer, Kite Pharma; David Fajgenbaum, MD, MBA, MSc, Assistant Professor of Medicine, University of Pennsylvania; Co-Founder/Executive Director, Castleman Disease Collaborative Network; Colin Hill, Cofounder, Chairman & Chief Executive Officer, GNS Healthcare; Sami Inkinen, Founder & Chief Executive Officer, Virta Health; Nick Leschly, Chief Executive Officer, Bluebird Bio; Jeffrey D. Marrazzo, Cofounder & Chief Executive Officer, Spark Therapeutics; Vijay Pande, Partner, Andreessen Horowitz; Martine Rothblatt, Chairman & Chief Executive Officer, United Therapeutics; Luhan Yang, Ph.D., Cofounder & Chief Scientific Officer, eGenesis Bio and Richard Rothman, MD, PhD, Founder, Rothman Institute, Thomas Jefferson University Hospital

Attendees of the summit include medical professionals, doctors, hospital executives, academics, researchers, venture capitalists, pharmaceutical firms, policymakers, philanthropists and future leaders.


Write a Reply or Comment:

Your email address will not be published.*